Molecular classification of cutaneous malignant melanoma by gene expression profiling.

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A (2001) 24.34

Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A (2001) 19.30

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med (2001) 16.65

Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol (2001) 15.02

Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A (2001) 13.30

Coexpression analysis of human genes across many microarray data sets. Genome Res (2004) 9.38

Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci U S A (2001) 7.51

WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer (2013) 6.64

A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity (2008) 5.89

A prediction-based resampling method for estimating the number of clusters in a dataset. Genome Biol (2002) 5.15

Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics (2006) 4.57

Discovering motifs in ranked lists of DNA sequences. PLoS Comput Biol (2007) 4.40

Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci U S A (2001) 4.20

Bootstrapping cluster analysis: assessing the reliability of conclusions from microarray experiments. Proc Natl Acad Sci U S A (2001) 4.04

Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res (2004) 3.83

Specificity of short interfering RNA determined through gene expression signatures. Proc Natl Acad Sci U S A (2003) 3.74

Revisiting global gene expression analysis. Cell (2012) 3.63

Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol (2001) 3.55

Gene expression analyses reveal molecular relationships among 20 regions of the human CNS. Neurogenetics (2006) 3.40

The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem (2007) 3.24

Correspondence analysis applied to microarray data. Proc Natl Acad Sci U S A (2001) 3.19

Subsystem identification through dimensionality reduction of large-scale gene expression data. Genome Res (2003) 3.06

The gene expression signatures of melanoma progression. Proc Natl Acad Sci U S A (2005) 3.05

Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci U S A (2002) 3.05

Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A (2001) 3.01

A Wnt survival guide: from flies to human disease. J Invest Dermatol (2009) 2.91

Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J Virol (2003) 2.91

A DNA microarray survey of gene expression in normal human tissues. Genome Biol (2005) 2.90

Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol (2009) 2.89

Penetration of the stigma and style elicits a novel transcriptome in pollen tubes, pointing to genes critical for growth in a pistil. PLoS Genet (2009) 2.83

Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS One (2007) 2.77

Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents. Proc Natl Acad Sci U S A (2002) 2.72

miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One (2011) 2.70

Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci U S A (2006) 2.60

Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc Natl Acad Sci U S A (2002) 2.52

Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci U S A (2008) 2.51

A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov (2014) 2.51

IAP regulation of metastasis. Cancer Cell (2010) 2.47

Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci U S A (2009) 2.41

An assessment of Motorola CodeLink microarray performance for gene expression profiling applications. Nucleic Acids Res (2002) 2.37

Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci U S A (2001) 2.36

Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes. BMC Bioinformatics (2005) 2.36

Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus). J Virol (2001) 2.31

Sources of variability and effect of experimental approach on expression profiling data interpretation. BMC Bioinformatics (2002) 2.31

Spectral biclustering of microarray data: coclustering genes and conditions. Genome Res (2003) 2.25

Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res (2001) 2.25

Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci U S A (2001) 2.22

Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS One (2009) 2.21

Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Res (2002) 2.21

A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS. Proc Natl Acad Sci U S A (2003) 2.19

Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc Natl Acad Sci U S A (2003) 2.10

Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data. Br J Cancer (2003) 2.08

Mutation of melanosome protein RAB38 in chocolate mice. Proc Natl Acad Sci U S A (2002) 2.02

Clustering cancer gene expression data: a comparative study. BMC Bioinformatics (2008) 2.00

Integrative genome comparison of primary and metastatic melanomas. PLoS One (2010) 1.97

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol (2001) 1.95

3'-end sequencing for expression quantification (3SEQ) from archival tumor samples. PLoS One (2010) 1.91

Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol (2001) 1.89

Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays. Am J Pathol (2001) 1.88

The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst (2013) 1.76

The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene (2009) 1.75

Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol (2006) 1.75

Large-scale integration of cancer microarray data identifies a robust common cancer signature. BMC Bioinformatics (2007) 1.74

Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification. BMC Genomics (2007) 1.74

Expression profiling to predict outcome in breast cancer: the influence of sample selection. Breast Cancer Res (2002) 1.72

Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. Proc Natl Acad Sci U S A (2006) 1.67

Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res (2008) 1.65

Human transcriptome array for high-throughput clinical studies. Proc Natl Acad Sci U S A (2011) 1.62

Spurious spatial periodicity of co-expression in microarray data due to printing design. Nucleic Acids Res (2003) 1.61

CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumors. J Invest Dermatol (2008) 1.60

Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect. Curr Drug Discov Technol (2009) 1.60

Tumor cell vasculogenic mimicry: from controversy to therapeutic promise. Am J Pathol (2012) 1.58

RNA amplification for successful gene profiling analysis. J Transl Med (2005) 1.55

Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications. Clin Cancer Res (2012) 1.52

A re-evaluation of the "oncogenic" nature of Wnt/beta-catenin signaling in melanoma and other cancers. Curr Oncol Rep (2010) 1.52

An immunologic portrait of cancer. J Transl Med (2011) 1.50

Tests for finding complex patterns of differential expression in cancers: towards individualized medicine. BMC Bioinformatics (2004) 1.49

Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma. Neoplasia (2010) 1.48

CD155/PVR plays a key role in cell motility during tumor cell invasion and migration. BMC Cancer (2004) 1.48

The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors. Am J Pathol (2003) 1.47

Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol (2002) 1.46

A comparative study of different machine learning methods on microarray gene expression data. BMC Genomics (2008) 1.46

Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement. J Natl Cancer Inst (2011) 1.45

Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. J Natl Cancer Inst (2009) 1.44

The computational analysis of scientific literature to define and recognize gene expression clusters. Nucleic Acids Res (2003) 1.44

Expression profiling of human tumors: the end of surgical pathology? J Mol Diagn (2001) 1.43

Breast cancer prognosis by combinatorial analysis of gene expression data. Breast Cancer Res (2006) 1.43

Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer Res (2008) 1.41

AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene (2010) 1.40

Endothelin 1 in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer (2013) 1.40

Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test. J Hematol Oncol (2017) 1.39

Investing in new technology: the PET experience. Br J Cancer (2003) 1.39

Strengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER Diagnostic Signature Challenge. Bioinformatics (2013) 1.39

Cluster stability scores for microarray data in cancer studies. BMC Bioinformatics (2003) 1.36

Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation. Am J Pathol (2001) 1.33

Melanoma prognostic model using tissue microarrays and genetic algorithms. J Clin Oncol (2009) 1.33

Biological properties and gene expression associated with metastatic potential of human osteosarcoma. Clin Exp Metastasis (2003) 1.32

An entropy-based gene selection method for cancer classification using microarray data. BMC Bioinformatics (2005) 1.32

Wnt5A activates the calpain-mediated cleavage of filamin A. J Invest Dermatol (2009) 1.32

Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. J Transl Med (2009) 1.31

The Ensembl genome database project. Nucleic Acids Res (2002) 40.87

Gene-expression profiles in hereditary breast cancer. N Engl J Med (2001) 29.80

Ensembl 2009. Nucleic Acids Res (2008) 25.38

Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest (2001) 23.21

Ensembl 2008. Nucleic Acids Res (2007) 20.67

Ensembl 2007. Nucleic Acids Res (2006) 20.10

Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics (1975) 18.25

Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet (1996) 15.73

Ensembl 2005. Nucleic Acids Res (2005) 15.13

Flexible regression models with cubic splines. Stat Med (1989) 14.45

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35

Ensembl 2002: accommodating comparative genomics. Nucleic Acids Res (2003) 12.26

Ensembl 2004. Nucleic Acids Res (2004) 11.88

Ensembl 2006. Nucleic Acids Res (2006) 11.66

Expression profiling using cDNA microarrays. Nat Genet (1999) 11.58

Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature (1999) 10.97

Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J Biol Chem (1999) 10.14

The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40

Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci U S A (2006) 9.26

The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell (2000) 8.95

Signaling of cell fate decisions by CLAVATA3 in Arabidopsis shoot meristems. Science (1999) 8.61

Data management and analysis for gene expression arrays. Nat Genet (1998) 8.60

Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res (2001) 8.34

Ratio-based decisions and the quantitative analysis of cDNA microarray images. J Biomed Opt (1997) 8.32

The CONSTANS gene of Arabidopsis promotes flowering and encodes a protein showing similarities to zinc finger transcription factors. Cell (1995) 7.76

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science (2001) 7.66

The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science (2001) 6.90

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature (2001) 6.78

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene (2007) 6.55

Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science (1997) 6.23

Cognitive deficits associated with blood lead concentrations <10 microg/dL in US children and adolescents. Public Health Rep (2001) 6.12

Dependence of stem cell fate in Arabidopsis on a feedback loop regulated by CLV3 activity. Science (2000) 6.05

Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science (1999) 5.95

A cortical area selective for visual processing of the human body. Science (2001) 5.92

Plasmid vectors for the genetic analysis and manipulation of rhizobia and other gram-negative bacteria. Methods Enzymol (1986) 5.58

Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A (2001) 5.48

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature (1997) 5.45

Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science (1994) 5.37

High frequency mobilization of gram-negative bacterial replicons by the in vitro constructed Tn5-Mob transposon. Mol Gen Genet (1984) 5.35

Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J (1998) 5.34

Tumor induction of VEGF promoter activity in stromal cells. Cell (1998) 5.20

Contextual cueing: implicit learning and memory of visual context guides spatial attention. Cogn Psychol (1998) 5.17

Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A (1998) 5.15

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol (1996) 5.09

A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet (2001) 5.06

Tissue classification with gene expression profiles. J Comput Biol (2000) 5.06

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci U S A (1996) 5.04

Cross-bridge model of muscle contraction. Quantitative analysis. Biophys J (1980) 4.91

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med (2001) 4.83

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood (1997) 4.78

Prevention of fat-induced insulin resistance by salicylate. J Clin Invest (2001) 4.74

Clustering gene expression patterns. J Comput Biol (1999) 4.69

Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res (1998) 4.68

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature (2000) 4.66

Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature (1997) 4.59

The potential for improved teamwork to reduce medical errors in the emergency department. The MedTeams Research Consortium. Ann Emerg Med (1999) 4.59

Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res (2001) 4.51

Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet (2001) 4.48

Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst (1998) 4.32

Statistical aspects of prognostic factor studies in oncology. Br J Cancer (1994) 4.22

Drug-induced changes of cytoskeletal structure and mechanics in fibroblasts: an atomic force microscopy study. Biophys J (2000) 4.14

Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology (1998) 4.13

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science (1994) 3.96

Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem (2000) 3.90

Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination. J Clin Epidemiol (1990) 3.88

Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res (1998) 3.85

Bayesian variable selection method for censored survival data. Biometrics (1998) 3.84

Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res (2000) 3.83

Testing for qualitative interactions between treatment effects and patient subsets. Biometrics (1985) 3.71

Evidence that the src gene product of Rous sarcoma virus is membrane associated. Virology (1980) 3.71

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet (2002) 3.67

A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol (1998) 3.65

Interference of GTP hydrolysis in the mechanism of microtubule assembly: an experimental study. Proc Natl Acad Sci U S A (1984) 3.63

Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem (1996) 3.63

A molecular link between stem cell regulation and floral patterning in Arabidopsis. Cell (2001) 3.55

TRAPP, a highly conserved novel complex on the cis-Golgi that mediates vesicle docking and fusion. EMBO J (1998) 3.49

Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science (1999) 3.47

Sample size requirements for evaluating a conservative therapy. Cancer Treat Rep (1978) 3.38

Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature (1996) 3.37

Dimensional and mechanical dynamics of active and stable edges in motile fibroblasts investigated by using atomic force microscopy. Proc Natl Acad Sci U S A (1999) 3.33

Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev (1996) 3.32

Cooperative effects in models of steady-state transport across membranes. 3. Simulation of potassium ion transport in nerve. Proc Natl Acad Sci U S A (1970) 3.30

Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci (2002) 3.28

Mechanism of the cardiotoxic actions of terfenadine. JAMA (1993) 3.27

Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc Natl Acad Sci U S A (1998) 3.27

Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science (1998) 3.26

Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol Biol Cell (1996) 3.23